244 related articles for article (PubMed ID: 18408764)
1. FLASH acts as a co-activator of the transcription factor c-Myb and localizes to active RNA polymerase II foci.
Alm-Kristiansen AH; Saether T; Matre V; Gilfillan S; Dahle O; Gabrielsen OS
Oncogene; 2008 Aug; 27(34):4644-56. PubMed ID: 18408764
[TBL] [Abstract][Full Text] [Related]
2. PIAS1 interacts with FLASH and enhances its co-activation of c-Myb.
Alm-Kristiansen AH; Lorenzo PI; Molværsmyr AK; Matre V; Ledsaak M; Sæther T; Gabrielsen OS
Mol Cancer; 2011 Feb; 10():21. PubMed ID: 21338522
[TBL] [Abstract][Full Text] [Related]
3. HIPK1 interacts with c-Myb and modulates its activity through phosphorylation.
Matre V; Nordgård O; Alm-Kristiansen AH; Ledsaak M; Gabrielsen OS
Biochem Biophys Res Commun; 2009 Oct; 388(1):150-4. PubMed ID: 19646965
[TBL] [Abstract][Full Text] [Related]
4. BS69, an adenovirus E1A-associated protein, inhibits the transcriptional activity of c-Myb.
Ladendorff NE; Wu S; Lipsick JS
Oncogene; 2001 Jan; 20(1):125-32. PubMed ID: 11244510
[TBL] [Abstract][Full Text] [Related]
5. Tumorigenic N-terminal deletions of c-Myb modulate DNA binding, transactivation, and cooperativity with C/EBP.
Oelgeschläger M; Kowenz-Leutz E; Schreek S; Leutz A; Lüscher B
Oncogene; 2001 Nov; 20(50):7420-4. PubMed ID: 11704872
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M.
Oelgeschläger M; Janknecht R; Krieg J; Schreek S; Lüscher B
EMBO J; 1996 Jun; 15(11):2771-80. PubMed ID: 8654374
[TBL] [Abstract][Full Text] [Related]
7. Ribosomal protein L4 positively regulates activity of a c-myb proto-oncogene product.
Egoh A; Nosuke Kanesashi S; Kanei-Ishii C; Nomura T; Ishii S
Genes Cells; 2010 Aug; 15(8):829-41. PubMed ID: 20604807
[TBL] [Abstract][Full Text] [Related]
8. c-Myb protein interacts with Rcd-1, a component of the CCR4 transcription mediator complex.
Haas M; Siegert M; Schürmann A; Sodeik B; Wolfes H
Biochemistry; 2004 Jun; 43(25):8152-9. PubMed ID: 15209511
[TBL] [Abstract][Full Text] [Related]
9. c-Myb associates with PML in nuclear bodies in hematopoietic cells.
Dahle Ø; Bakke O; Gabrielsen OS
Exp Cell Res; 2004 Jul; 297(1):118-26. PubMed ID: 15194430
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
Lee J; Rhee BK; Bae GY; Han YM; Kim J
Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
[TBL] [Abstract][Full Text] [Related]
11. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.
Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M
Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127
[TBL] [Abstract][Full Text] [Related]
12. DNA binding-independent transcriptional activation of the vascular endothelial growth factor gene (VEGF) by the Myb oncoprotein.
Lutwyche JK; Keough RA; Hunter J; Coles LS; Gonda TJ
Biochem Biophys Res Commun; 2006 Jun; 344(4):1300-7. PubMed ID: 16650815
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb.
Zor T; De Guzman RN; Dyson HJ; Wright PE
J Mol Biol; 2004 Mar; 337(3):521-34. PubMed ID: 15019774
[TBL] [Abstract][Full Text] [Related]
14. FLASH interacts with p160 coactivator subtypes and differentially suppresses transcriptional activity of steroid hormone receptors.
Kino T; Ichijo T; Chrousos GP
J Steroid Biochem Mol Biol; 2004 Dec; 92(5):357-63. PubMed ID: 15698540
[TBL] [Abstract][Full Text] [Related]
15. c-Myb function in fibroblasts.
Bein K; Husain M; Ware JA; Mucenski ML; Rosenberg RD; Simons M
J Cell Physiol; 1997 Dec; 173(3):319-26. PubMed ID: 9369944
[TBL] [Abstract][Full Text] [Related]
16. [Regulation of transcription factors c-myb and liver activator protein on expression of alpha1(I) collagen gene in activated hepatic stellate cells].
Liu X
Zhonghua Gan Zang Bing Za Zhi; 2000 Oct; 8(5):279-81. PubMed ID: 11058951
[TBL] [Abstract][Full Text] [Related]
17. c-Maf interacts with c-Myb to down-regulate Bcl-2 expression and increase apoptosis in peripheral CD4 cells.
Peng S; Lalani S; Leavenworth JW; Ho IC; Pauza ME
Eur J Immunol; 2007 Oct; 37(10):2868-80. PubMed ID: 17823980
[TBL] [Abstract][Full Text] [Related]
18. Histone H3 tail positioning and acetylation by the c-Myb but not the v-Myb DNA-binding SANT domain.
Mo X; Kowenz-Leutz E; Laumonnier Y; Xu H; Leutz A
Genes Dev; 2005 Oct; 19(20):2447-57. PubMed ID: 16195416
[TBL] [Abstract][Full Text] [Related]
19. The human neuroendocrine thyrotropin-releasing hormone receptor promoter is activated by the haematopoietic transcription factor c-Myb.
Matre V; Høvring PI; Fjeldheim AK; Helgeland L; Orvain C; Andersson KB; Gautvik KM; Gabrielsen OS
Biochem J; 2003 Jun; 372(Pt 3):851-9. PubMed ID: 12628004
[TBL] [Abstract][Full Text] [Related]
20. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
Aikawa Y; Nguyen LA; Isono K; Takakura N; Tagata Y; Schmitz ML; Koseki H; Kitabayashi I
EMBO J; 2006 Sep; 25(17):3955-65. PubMed ID: 16917507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
